Niacin Therapy

Published Online: Sunday, September 1, 2002

Previous reports have shown that niacin in high doses raises blood glucose, but new evidence shows niacin therapy was well tolerated and resulted in minimal changes in glycemic control, said Scott M. Grundy, MD, PhD (director of the Center for Human Nutrition at the University of Texas Southwestern Medical Center, Dallas), and the lead author of a new study, the results of which were published in the July 2002 issue of the Archives of Internal Medicine.

The study found that ?good? (high-density lipoprotein) cholesterol increased by between 13% and 24%, depending on the strength of the dose, and that levels of ?bad? (low-density lipoprotein) cholesterol fell. ?This targeted approach may represent the best treatment strategy for achieving substantial reductions in the high and growing incidence of [heart disease] among patients with diabetes,? the authors concluded.

Latest Articles
Donnie Calhoun, RPh, PD, National Community Pharmacists Association (NCPA) Foundation vice president, discusses how pharmacists can prepare themselves and their business before, during, and after a disaster.
Ken Whittemore Jr, Surescript's senior vice president of professional and regulatory affairs, talks about some new transactions available that can help pharmacists.
In case you got caught up in the Thanksgiving holiday rush, here are the top trending stories you may have missed in November:
Bryan Ziegler, PharmD, executive director of Kennedy Pharmacy Innovation Center, provides some resources for community pharmacists to use when implementing new collaborative services with primary care providers.
Latest Issues